Related references
Note: Only part of the references are listed.Yellow Fever Vaccination and Increased Relapse Rate in Travelers With Multiple Sclerosis
Mauricio F. Farez et al.
ARCHIVES OF NEUROLOGY (2011)
Neurovirulence tests of three 17D yellow fever vaccine strains
Philip D. Minor
BIOLOGICALS (2011)
Probable transmission of vaccine strain of yellow fever virus to an infant via breast milk
Susan Kuhn et al.
CANADIAN MEDICAL ASSOCIATION JOURNAL (2011)
Why is PTPN22 a good candidate susceptibility gene for autoimmune disease?
Garth L. Burn et al.
FEBS LETTERS (2011)
Detection of Yellow Fever 17D Genome in Urine
Cristina Domingo et al.
JOURNAL OF CLINICAL MICROBIOLOGY (2011)
The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever
Emily S. Jentes et al.
LANCET INFECTIOUS DISEASES (2011)
An Inactivated Cell-Culture Vaccine against Yellow Fever
Thomas P. Monath et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Active and passive surveillance of yellow fever vaccine 17D or 17DD-associated serious adverse events: Systematic review
Roger E. Thomas et al.
VACCINE (2011)
Immune correlates of protection against yellow fever determined by passive immunization and challenge in the hamster model
Justin G. Julander et al.
VACCINE (2011)
Persistence of yellow fever vaccine RNA in urine
Miguel J. Martinez et al.
VACCINE (2011)
Characterization of main cytokine sources from the innate and adaptive immune responses following primary 17DD yellow fever vaccination in adults
Maria Luiza Silva et al.
VACCINE (2011)
The Flvr-encoded murine oligoadenylate synthetase 1b (Oas1b) suppresses 2-5A synthesis in intact cells
H. Elbahesh et al.
VIROLOGY (2011)
The Need for Organization and Collaboration: Establishing a Thymoma Registry
Pascal A. Thomas
THORACIC SURGERY CLINICS (2011)
Yellow Fever Virus Vaccine-associated Deaths in Young Women
Stephen J. Seligman
EMERGING INFECTIOUS DISEASES (2011)
Perinatal Transmission of Yellow Fever, Brazil, 2009
Maria Regina Bentlin et al.
EMERGING INFECTIOUS DISEASES (2011)
Short Report: Suspected Yellow Fever Vaccine-Associated Viscerotropic Adverse Events (1973 and 1978), United States
Thomas P. Monath
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2010)
Immunogenicity and Tolerability of Yellow Fever Vaccination in 23 French HIV-Infected Patients
Thierry Pistone et al.
CURRENT HIV RESEARCH (2010)
Variability in the 2′-5′-Oligoadenylate Synthetase Gene Cluster Is Associated with Human Predisposition to Tick-Borne Encephalitis Virus-Induced Disease
Andrey V. Barkhash et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Persistent Infection with West Nile Virus Years after Initial Infection
Kristy Murray et al.
JOURNAL OF INFECTIOUS DISEASES (2010)
Knowledge, Attitudes, and Practices of Japanese Travelers on Infectious Disease Risks and Immunization Uptake
Kyoko Namikawa et al.
JOURNAL OF TRAVEL MEDICINE (2010)
Yellow fever vaccination coverage among children in Brazilian capitals
Maria Amelia S. M. Veras et al.
VACCINE (2010)
WHO Working Group on Technical Specifications for Manufacture and Evaluation of Yellow Fever Vaccines, Geneva, Switzerland, 13–14 May 2009
Morag Ferguson et al.
VACCINE (2010)
Inactivated yellow fever 17D vaccine: Development and nonclinical safety, immunogenicity and protective activity
Thomas P. Monath et al.
VACCINE (2010)
Short Report: Incidence of Yellow Fever Vaccine-Associated Neurotropic Disease
Thomas Guimard et al.
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE (2009)
Population-Based Lupus Registries: Advancing Our Epidemiologic Understanding
S. Sam Lim et al.
ARTHRITIS CARE & RESEARCH (2009)
Immunogenicity and Safety of Yellow Fever Vaccination for 102 HIV-Infected Patients
Olivia Veit et al.
CLINICAL INFECTIOUS DISEASES (2009)
Yellow fever vaccine - how does it work and why do rare cases of serious adverse events take place?
Alan D. T. Barrett et al.
CURRENT OPINION IN IMMUNOLOGY (2009)
Safety of 17D derived yellow fever vaccines
Cristina Domingo et al.
EXPERT OPINION ON DRUG SAFETY (2009)
Population-based study of autoimmune conditions and the risk of specific lymphoid malignancies
Lesley A. Anderson et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Yellow Fever in a Brazilian Family Returning From Vacation in an Endemic Area: Relevant Clinical Features and Epidemiological Issues
Tania S. S. Chaves et al.
JOURNAL OF TRAVEL MEDICINE (2009)
Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans
Troy D. Querec et al.
NATURE IMMUNOLOGY (2009)
Yellow Fever Vaccination and Kawasaki Disease
Deonilson Schmoeller et al.
PEDIATRIC INFECTIOUS DISEASE JOURNAL (2009)
Vaccination as a Triggering Event for Autoimmune Hepatitis
Ponni Perumalswami et al.
SEMINARS IN LIVER DISEASE (2009)
Reduced intradermal test dose of yellow fever vaccine induces protective immunity in individuals with egg allergy
Anna H. Roukens et al.
VACCINE (2009)
Monitoring adverse events following yellow fever vaccination using an integrated telephone and Internet-based system
Anna P. Durbin et al.
VACCINE (2009)
Viscerotropic disease following yellow fever vaccination in Peru
Alvaro Whittembury et al.
VACCINE (2009)
A Mouse Model for Studying Viscerotropic Disease Caused by Yellow Fever Virus Infection
Kathryn C. Meier et al.
PLOS PATHOGENS (2009)
Genetic Variation in OAS1 Is a Risk Factor for Initial Infection with West Nile Virus in Man
Jean K. Lim et al.
PLOS PATHOGENS (2009)
Anamnestic Immune Response to Dengue and Decreased Severity of Yellow Fever
Ricardo O. Izurieta et al.
JOURNAL OF GLOBAL INFECTIOUS DISEASES (2009)
Yellow fever vaccines and international travelers
Elizabeth D. Barnett et al.
EXPERT REVIEW OF VACCINES (2008)
Yellow fever vaccine induces integrated multilineage and polyfunctional immune responses
Denis Gaucher et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2008)
Persistent infection and associated nucleotide changes of West Nile virus serially passaged in hamsters
Xiaoyan Wu et al.
JOURNAL OF GENERAL VIROLOGY (2008)
Immune response during adverse events after 17D-derived yellow fever vaccination in Europe
Hi-Gung Bae et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Case of yellow fever vaccine-associated viscerotropic disease with prolonged viremia, robust adaptive immune responses, and polymorphisms in CCR5 and RANTES genes
Bali Pulendran et al.
JOURNAL OF INFECTIOUS DISEASES (2008)
Adverse event reports following yellow fever vaccination
Nicole P. Lindsey et al.
VACCINE (2008)
Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease
Jon L. Belsher et al.
VACCINE (2007)
Acute viscerotropic disease following vaccination against yellow fever
Edward B. Hayes
TRANSACTIONS OF THE ROYAL SOCIETY OF TROPICAL MEDICINE AND HYGIENE (2007)
Factors influencing standard pretravel health advice - A study in Belgium
Kristina Van De Winkel et al.
JOURNAL OF TRAVEL MEDICINE (2007)
Spanish travelers to high-risk areas in the tropics: Airport survey of travel health knowledge, attitudes, and practices in vaccination and malaria prevention
Rogelio Lopez-Velez et al.
JOURNAL OF TRAVEL MEDICINE (2007)
Early exposure to yellow fever vaccine during pregnancy
Denise P. Cavalcanti et al.
TROPICAL MEDICINE & INTERNATIONAL HEALTH (2007)
High stability of yellow fever 17D-204 vaccine:: A 12-year restrospective analysis of large-scale production
V. Barban et al.
VACCINE (2007)
Herpes zoster after yellow fever vaccination
Jose-Maria Bayas et al.
JOURNAL OF TRAVEL MEDICINE (2007)
Multiple evanescent white dot syndrome following simultaneous hepatitis-A and yellow fever vaccination
Alexandros Stangos et al.
OCULAR IMMUNOLOGY AND INFLAMMATION (2006)
A live, attenuated recombinant West Nile virus vaccine
TP Monath et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2006)
The effects of yellow fever immunization (17DD) inadvertently used in early pregnancy during a mass campaign in Brazil
CES Suzano et al.
VACCINE (2006)
CCR5 deficiency increases risk of symptomatic West Nile virus infection
WG Glass et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2006)
Chemokine receptor CCR5 promotes leukocyte trafficking to the brain and survival in West Nile virus infection
WG Glass et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
Yellow Fever 17D Vaccine Safety and Immunogenicity in the Elderly
Thomas P. Monath et al.
HUMAN VACCINES (2005)
Reactogenicity of yellow fever vaccines in a randomized, placebo-controlled trial
LAB Camacho et al.
REVISTA DE SAUDE PUBLICA (2005)
Yellow fever vaccine: An updated assessment of advanced age as a risk factor for serious adverse events
AY Khromava et al.
VACCINE (2005)
History of thymoma and yellow fever vaccination
RB Eidex
LANCET (2004)
Safety of the yellow fever vaccine during the September 2001 mass vaccination campaign in Abidjan, Ivory Coast
J Fitzner et al.
VACCINE (2004)
Vaccine policy changes and epidemiology of poliomyelitis in the United States
LN Alexander et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2004)
Travel health knowledge, attitudes and practices among United States travelers
DH Hamer et al.
JOURNAL OF TRAVEL MEDICINE (2004)
Neuroadapted yellow fever virus 17D: Determinants in the envelope protein govern neuroinvasiveness for SCID mice
M Nickells et al.
JOURNAL OF VIROLOGY (2003)
Inflammatory causes of gastroparesis: Report of five cases
H Pande et al.
DIGESTIVE DISEASES AND SCIENCES (2002)
Positional cloning of the murine flavivirus resistance gene
AA Perelygin et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Prevention of yellow fever in persons traveling to the tropics
TP Monath et al.
CLINICAL INFECTIOUS DISEASES (2002)
Advanced age a risk factor for illness temporally associated with yellow fever vaccination
M Martin et al.
EMERGING INFECTIOUS DISEASES (2001)
Hepatitis and death following vaccination with 17D-204 yellow fever vaccine
RC Chan et al.
LANCET (2001)
Fever and multisystem organ failure associated with 17D-204 yellow fever vaccination: a report of four cases
M Martin et al.
LANCET (2001)
Serious adverse events associated with yellow fever 17DD vaccine in Brazil: a report of two cases
PFC Vasconcelos et al.
LANCET (2001)
Persistence of arboviruses and antiviral antibodies in vertebrate hosts: its occurrence and impacts
G Kuno
REVIEWS IN MEDICAL VIROLOGY (2001)
Attenuation of tick-borne encephalitis virus by structure-based site-specific mutagenesis of a putative flavivirus receptor binding site
CW Mandl et al.
JOURNAL OF VIROLOGY (2000)
Share Paper
